https://drugnews.com.tw/articles/2026-08-28-zealand-rusfertide-royalty-pharma-pv-en.html Drugnews｜藥時事 en 2026-08-28T00:00:00.000Z A New Rival for PharmaEssentia? What Zealand Actually Sold for $100 Million https://drugnews.com.tw/articles/2026-08-28-zealand-rusfertide-royalty-pharma-pv.html Drugnews｜藥時事 zh-tw 2026-08-28T00:00:00.000Z 藥華藥迎新對手？1 億美元賣分潤 https://drugnews.com.tw/articles/2026-08-27-twist-dna-ai-drug-discovery-shovels-en.html Drugnews｜藥時事 en 2026-08-27T00:00:00.000Z DNA Is Not the Nvidia of AI Drug Discovery, At Least Not Yet https://drugnews.com.tw/articles/2026-08-27-twist-dna-ai-drug-discovery-shovels.html Drugnews｜藥時事 zh-tw 2026-08-27T00:00:00.000Z DNA 不是 AI 製藥的輝達，至少現在還不是